Empower Advisory Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1978885 Greenwood Village, CO

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$321,537,224

+$82,606,732 QoQ

Shares Held

268,075

+3.2% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

1.93%

of 13F equity value

Holder Rank

#204

of 4,605 holders

Holding Since

Mar 2023

14 quarters on record

Healthcare · as of Jun 30, 2026

Empower Advisory Group, LLC holds $946,768,864 across 11 Drug Manufacturers - General names. LLY ranks #1 (34.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	268,075	$321,537,224
2	JNJ	Johnson & Johnson	905,317	$229,923,358
3	ABBV	AbbVie Inc.	507,376	$127,676,096
4	AMGN	Amgen Inc	349,667	$126,621,414
5	PFE	Pfizer Inc	4,830,581	$116,320,390
6	MRK	Merck & Co., Inc.	169,726	$21,809,791
7	AZN	Astrazeneca PLC	5,682	$1,077,420
8	GILD	Gilead Sciences, Inc.	7,129	$900,677

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$321,537,224	268,075	+3.2%	Shares	Sole	2026-08-12
2026-03-31	$238,930,492	259,772	+4.1%	Shares	Sole	2026-05-14
2025-12-31	$268,241,227	249,601	+1.6%	Shares	Sole	2026-02-12
2025-09-30	$187,389,748	245,596	+8.7%	Shares	Sole	2025-11-14
2025-06-30	$176,122,331	225,934	+6.3%	Shares	Sole	2025-08-08
2025-03-31	$175,521,567	212,519	+9.8%	Shares	Sole	2025-05-09
2024-12-31	$149,371,192	193,486	+38.9%	Shares	Sole	2025-01-31
2024-09-30	$123,388,407	139,274	+4.3%	Shares	Sole	2024-11-05
2024-06-30	$120,951,524	133,592	+6.1%	Shares	Sole	2024-07-25
2024-03-31	$97,937,384	125,890	+291.5%	Shares	Sole	2024-05-02
2023-12-31	$18,743,209	32,154	-6.4%	Shares	Sole	2024-02-07
2023-09-30	$18,448,266	34,346	-4.5%	Shares	Sole	2023-11-06
2023-06-30	$16,869,679	35,971	-2.3%	Shares	Sole	2023-08-10
2023-03-31	$12,639,573	36,805	—	Shares	Sole	2023-05-25
No filing history on record for this holder in this stock.